Literature DB >> 6338437

Ocular manifestations of graft-vs-host disease.

R M Franklin, K R Kenyon, P J Tutschka, R Saral, W R Green, G W Santos.   

Abstract

In patients who have graft-vs-host disease (GVHD) after bone marrow transplantation, ocular involvement occurs in approximately 60% of cases. Among 13 such GVHD patients, the most frequent ocular manifestations included keratoconjunctivitis sicca, cicatricial lagophthalmos, and sterile conjunctivitis and uveitis. The severe ocular complications of persistent corneal epithelial defects and both noninfected and infected stromal ulceration were related to the concomitant dry-eye condition and could be managed by conventional therapy including topical lubricants and antibiotics, punctal occlusion, bandage soft contact lenses, tarsorrhaphy, tissue adhesive, conjunctival flap, and conjunctival homograft. Postmortem and surgical tissues from four patients revealed conjunctival and corneal epithelial thinning and keratinization, lacrimal inspissation without inflammatory infiltration, and diffuse choroiditis. Keratoconjunctivitis sicca in GVHD patients might be a combined result of drug toxicity effects and GVHD. The frequent and potentially severe ocular problems in these patients suggest that close ophthalmic monitoring is mandatory in bone marrow transplant recipients.

Entities:  

Mesh:

Year:  1983        PMID: 6338437     DOI: 10.1016/s0161-6420(83)34604-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  25 in total

Review 1.  Management of graft-versus-host disease in paediatric bone marrow transplant recipients.

Authors:  M Zecca; F Locatelli
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  Irradiation cataract in children after bone marrow transplantation.

Authors:  M Lappi; J Rajantie; R J Uusitalo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal Model.

Authors:  Victor L Perez; Alexander Barsam; Stephanie Duffort; Maitee Urbieta; Henry Barreras; Casey Lightbourn; Krishna V Komanduri; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-01       Impact factor: 5.742

4.  Dry eye after haematopoietic stem cell transplantation.

Authors:  Y Ogawa; S Okamoto; M Wakui; R Watanabe; M Yamada; M Yoshino; M Ono; H Y Yang; Y Mashima; Y Oguchi; Y Ikeda; K Tsubota
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

5.  Penetrating keratoplasty in severe ocular graft versus host disease.

Authors:  J D Heath; J F Acheson; W E Schulenburg
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

6.  Multiple cotton wool spots following bone marrow transplantation for treatment of acute lymphatic leukaemia.

Authors:  B Gloor; A Gratwohl; H Hahn; S Kretzschmar; Y Robert; B Speck; B Daicker
Journal:  Br J Ophthalmol       Date:  1985-05       Impact factor: 4.638

7.  Ocular complications in children after hematopoietic stem cell transplantation without total body irradiation.

Authors:  Michael Kinori; Bella Bielorai; Daniel Souroujon; Dafna Hutt; Iris Ben-Bassat Mizrachi; Ruth Huna-Baron
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-24       Impact factor: 3.117

8.  Ocular complications of bone marrow transplantation.

Authors:  L C Bray; P J Carey; S J Proctor; R G Evans; P J Hamilton
Journal:  Br J Ophthalmol       Date:  1991-10       Impact factor: 4.638

9.  Bone-marrow transplantation and toxoplasmic retinochoroiditis.

Authors:  D Pauleikhoff; E Messmer; D W Beelen; M Foerster; A Wessing
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

10.  Dry Eye Disease Incidence Associated with Chronic Graft-Host Disease: Nonconcurrent Cohort Study (An American Ophthalmological Society Thesis).

Authors:  Shahzad I Mian; Paola De la Parra-Colín; Rafael De Melo-Franco; Christopher Johnson; Tonatiuh Barrientos-Gutierrez
Journal:  Trans Am Ophthalmol Soc       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.